- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02736994
Assessment of the Impact of Probiotics on Biofilm Formation on Removable Acrylic Dentures
April 7, 2016 updated by: Universitaire Ziekenhuizen KU Leuven
The aim of this study is to evaluate the effect of PIP toothbrush cleaner® on the microbial composition and Candida albicans colonization of denture biofilm formation.
Additionally, its effect will be compared to that of cleansing tablets.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Therefore the present study intended to compare a probiotic denture cleaning protocol with the current protocols.
It was aimed to examine, in institutionalized older individuals with removable complete dentures, if the microbial composition and C. albicans colonization of the denture biofilm differs when overnight stored in a probiotic cleaning product compared to water or a cleanser.
Additionally the influence of brushing on these protocols was investigated.
Study Type
Interventional
Enrollment (Actual)
13
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Leuven, Belgium, 3000
- Department of Oral Health Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Reside in a home for elderly
- Fully edentulous in lower and upper jaw
- Removable denture wearer in lower and upper jaw
- Good oral health
Exclusion Criteria:
- Current or history of corticosteroid treatment within the 3 months prior to the study
- Current or history of antimicrobial treatment within the 3 months prior to the study
- Inability to provide informed consent
- Inability to comply with the study requirements
- Heart disorders persons with a high risk for an unfavourable prognosis of bacterial endocarditis will be excluded. This applies to patients with prosthetic heart valves, history of infectious endocarditis, cyanogenic congenital heart disorders (including palliative shunts and connections), completely recovered congenital disorders that were treated less than 6 months ago, treated congenital heart disorders with residual defect, and valvulopathy after heart transplantation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Immersion in water
water
|
Water
|
|
Active Comparator: Immersion in water + cleansing tablet
Corega Tabs Anti-bacteria® (GlaxoSmithKline Consumer Healthcare SA, Genval, Belgium)
|
Cleansing tablet -Corega Tabs Anti-bacteria® (GlaxoSmithKline Consumer Healthcare SA, Genval, Belgium)
Other Names:
|
|
Experimental: Immersion in water with PIP
PIP toothbrush cleaner® (Chrisal, Lommel, Belgium)
|
Probiotic
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Candida albicans colonization
Time Frame: day 5
|
C. albicans colonization was the primary outcome measure of interest.
With a microbial test there was researched if C. albicans colonized the prostheses.
|
day 5
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Other microbiological counts Aa
Time Frame: day 5
|
The concentration of Aggregatibacter Actinomycetemcomitans was researched.
|
day 5
|
|
Other microbiological counts Pg
Time Frame: day 5
|
The concentration of Porphyromonas gingivalis was researched.
|
day 5
|
|
Other microbiological counts Tf
Time Frame: day 5
|
The concentration of Tannerella forsythensis was researched.
|
day 5
|
|
Other microbiological counts Td
Time Frame: day 5
|
The concentration of Treponema denticola was researched.
|
day 5
|
|
Other microbiological counts Pi
Time Frame: day 5
|
The concentration of Prevotella intermedia was researched.
|
day 5
|
|
Other microbiological counts Fn
Time Frame: day 5
|
The concentration of Fusobacterium nucleatum was researched.
|
day 5
|
|
Other microbiological counts Pm
Time Frame: day 5
|
The concentration of Peptostreptococcus micros was researched.
|
day 5
|
|
Other microbiological counts Pn
Time Frame: day 5
|
The concentration of Prevotella nigrescens was researched.
|
day 5
|
|
Other microbiological counts Cg
Time Frame: day 5
|
The concentration of Campylobacter gracilis was researched.
|
day 5
|
|
Other microbiological counts Cr
Time Frame: day 5
|
The concentration of Campylobacter rectus was researched.
|
day 5
|
|
Other microbiological counts En
Time Frame: day 5
|
The concentration of Eubacterium nodatum was researched.
|
day 5
|
|
Other microbiological counts Ec
Time Frame: day 5
|
The concentration of Eikenella corrodens was researched.
|
day 5
|
|
Other microbiological counts Capn
Time Frame: day 5
|
The concentration of Capnocytophaga species was researched.
|
day 5
|
|
Other microbiological counts Cc
Time Frame: day 5
|
The concentration of Campylobacter concisus count was researched.
|
day 5
|
|
Other microbiological counts mitis streptococci
Time Frame: day 5
|
Concentration of mitis streptococci
|
day 5
|
|
Other microbiological counts Sg
Time Frame: day 5
|
The concentration of Streptococcus gordonii
|
day 5
|
|
Other microbiological counts Sc
Time Frame: day 5
|
The concentration of Streptococcus constellatus.
|
day 5
|
|
Other microbiological counts Ao
Time Frame: day 5
|
The concentration of Actinomyces odontolyticus.
|
day 5
|
|
Other microbiological counts Av
Time Frame: day 5
|
The concentration of Actinomyces viscosus.
|
day 5
|
|
Other microbiological counts Vp
Time Frame: day 5
|
The concentration of Veillonella parvula.
|
day 5
|
|
Other microbiological counts total
Time Frame: day 5
|
Total bacterial count.
|
day 5
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Joke Duyck, DDS, PhD, Universitaire Ziekenhuizen KU Leuven
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2014
Primary Completion (Actual)
September 1, 2014
Study Completion (Actual)
September 1, 2014
Study Registration Dates
First Submitted
January 17, 2014
First Submitted That Met QC Criteria
April 7, 2016
First Posted (Estimate)
April 13, 2016
Study Record Updates
Last Update Posted (Estimate)
April 13, 2016
Last Update Submitted That Met QC Criteria
April 7, 2016
Last Verified
November 1, 2013
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- S56279
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mandibular Prosthesis User
-
Cairo UniversityUnknownMandibular Prosthesis UserEgypt
-
Cairo UniversityUnknownMandibular Prosthesis UserEgypt
-
Cairo UniversityUnknown
-
Ivory Graft Ltd.CompletedAlveolar Bone Grafting | Deficiency of Alveolar Ridge (Disorder) | Mandibular Prosthesis UserIsrael
-
Ivory Graft Ltd.Active, not recruitingAlveolar Bone Grafting | Deficiency of Alveolar Ridge (Disorder) | Mandibular Prosthesis UserIsrael
-
Liberating Technologies, Inc.Eunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedAmputation | Prosthesis | Prosthesis UserUnited States
-
University Medical Center GroningenZonMw: The Netherlands Organisation for Health Research and DevelopmentRecruitingAmputation | Prosthesis | Prosthesis UserNetherlands
-
University Medical Center GroningenZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedAmputation | Prosthesis | Prosthesis UserNetherlands
-
Liberating Technologies, Inc.Completed
-
Menoufia UniversityRecruiting
Clinical Trials on Water
-
Polyclinic of the Hospitaller Brothers of St. John...Enrolling by invitationLow Back Pain | Performance Measures | Fatigue RecoveryHungary
-
Essentia Water, LLCHealth Onvector Inc.Completed
-
University Hospital, MontpellierCompletedHealthy | Heat ExposureFrance
-
University of ManitobaCompleted
-
Imam Abdulrahman Bin Faisal UniversityThe Saline Water Conversion Corporation Research Institute at Al-Jubail,...CompletedDiabetes Mellitus | Glucose, High Blood | PatientsSaudi Arabia
-
Pharos University in AlexandriaActive, not recruiting
-
University of FloridaWithdrawnWeight Loss | Appetitive Behavior | Energy Intake | Water
-
Singapore General HospitalUnknown
-
University of Novi Sad, Faculty of Sport and Physical...Dom Zdravlja NisCompleted
-
Institute of Progressive MedicineActive, not recruiting